Seminars in Hematology
Volume 45, Supplement 1 , Pages S7-S11, April 2008

Further Understanding of Recombinant Activated Factor VII Mode of Action

  • Dougald M. Monroe

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dougald M. Monroe, PhD, Division of Hematology/Oncology, 932 Mary Ellen Jones Building, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7035.

Division of Hematology/Oncology, Department of Medicine, Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, Chapel Hill, NC.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dougald Monroe has a University of North Carolina-administered research grant funded by Novo Nordisk. He has also received honoraria from Novo Nordisk for speaking at meetings.

PII: S0037-1963(08)00053-X

doi:10.1053/j.seminhematol.2008.03.013

Seminars in Hematology
Volume 45, Supplement 1 , Pages S7-S11, April 2008

Article Tools

* Image Usage & Resolution